Anti-VEGF (vascular endothelial growth factor) drugs in diabetic macular oedema.
作者信息
Chhablani J K
出版信息
Eye (Lond). 2011 Feb;25(2):254; author reply 254. doi: 10.1038/eye.2010.182. Epub 2010 Dec 10.
Abstract
摘要
相似文献
1
Anti-VEGF (vascular endothelial growth factor) drugs in diabetic macular oedema.抗血管内皮生长因子（VEGF）药物治疗糖尿病性黄斑水肿
Eye (Lond). 2011 Feb;25(2):254; author reply 254. doi: 10.1038/eye.2010.182. Epub 2010 Dec 10.
2
Anti-VEGF therapeutic approaches for diabetic macular edema.用于治疗糖尿病性黄斑水肿的抗血管内皮生长因子治疗方法。
Int Ophthalmol Clin. 2009 Spring;49(2):109-19. doi: 10.1097/IIO.0b013e31819fd8b5.
3
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.采用抗血管内皮生长因子疗法治疗糖尿病性黄斑水肿的抗血管生成治疗
Cochrane Database Syst Rev. 2009 Oct 7(4):CD007419. doi: 10.1002/14651858.CD007419.pub2.
4
Anti-vascular endothelial growth factor for diabetic macular oedema.抗血管内皮生长因子治疗糖尿病性黄斑水肿
Cochrane Database Syst Rev. 2014 Oct 24(10):CD007419. doi: 10.1002/14651858.CD007419.pub4.
5
Anti-vascular endothelial growth factor agents for diabetic maculopathy.抗血管内皮生长因子药物治疗糖尿病性黄斑病变。
Br J Ophthalmol. 2010 Jul;94(7):821-6. doi: 10.1136/bjo.2009.163576. Epub 2009 Jun 24.
6
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.采用抗血管内皮生长因子疗法治疗糖尿病性黄斑水肿的抗血管生成治疗
Cochrane Database Syst Rev. 2012 Dec 12;12:CD007419. doi: 10.1002/14651858.CD007419.pub3.
7
Is intravitreal bevacizumab treatment effective in diffuse diabetic macular edema?
Graefes Arch Clin Exp Ophthalmol. 2009 Nov;247(11):1575-7. doi: 10.1007/s00417-009-1132-4. Epub 2009 Jul 7.
8
Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonide.玻璃体内注射贝伐单抗或曲安奈德治疗糖尿病性黄斑弥漫性水肿。
Acta Ophthalmol. 2010 Mar;88(2):e36-7. doi: 10.1111/j.1755-3768.2008.01443.x.
9
Diabetic macular oedema in 2011: what are the options for refractory cystic oedema?2011年糖尿病性黄斑水肿：难治性囊性水肿有哪些治疗选择？
Clin Exp Ophthalmol. 2011 Sep-Oct;39(7):595-7. doi: 10.1111/j.1442-9071.2011.02662.x.
10
Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.玻璃体内注射贝伐单抗与曲安奈德治疗持续性弥漫性糖尿病性黄斑水肿的疗效比较评估
Am J Ophthalmol. 2008 Dec;146(6):974; author reply 974-5. doi: 10.1016/j.ajo.2008.08.013.
引用本文的文献
1
Combination of Navigated Macular Laser Photocoagulation and Anti-VEGF Therapy: Precise Treatment for Macular Edema under Dry Retinal Conditions.导航黄斑激光光凝与抗VEGF治疗联合应用：干性视网膜条件下黄斑水肿的精准治疗
J Ophthalmol. 2017;2017:7656418. doi: 10.1155/2017/7656418. Epub 2017 Feb 20.
本文引用的文献
1
Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema.玻璃体内注射贝伐单抗与玻璃体内注射曲安奈德联合黄斑格栅激光治疗弥漫性糖尿病性黄斑水肿。
Eye (Lond). 2010 Aug;24(8):1325-30. doi: 10.1038/eye.2010.23. Epub 2010 Mar 19.
2
Steroid injection in addition to macular laser grid photocoagulation in diabetic macular oedema: a systematic review.类固醇注射联合黄斑激光网格光凝治疗糖尿病性黄斑水肿：系统评价。
Acta Ophthalmol. 2010 Jun;88(4):389-93. doi: 10.1111/j.1755-3768.2009.01657.x. Epub 2010 Mar 10.
3
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.采用抗血管内皮生长因子疗法治疗糖尿病性黄斑水肿的抗血管生成治疗
Cochrane Database Syst Rev. 2009 Oct 7(4):CD007419. doi: 10.1002/14651858.CD007419.pub2.
4
Pharmacokinetics of intravitreal bevacizumab (Avastin).玻璃体内注射贝伐单抗（阿瓦斯汀）的药代动力学
Ophthalmology. 2007 May;114(5):855-9. doi: 10.1016/j.ophtha.2007.01.017.
5
What we don't know about avastin might hurt us.我们对阿瓦斯汀不了解的方面可能会对我们不利。
Arch Ophthalmol. 2006 Oct;124(10):1478-9. doi: 10.1001/archopht.124.10.1478.
Zotero 插件